Mental Health

Those with attention-deficit/hyperactivity disorder are much more likely to have GAD at some point in their lives than others who do not have it.

Burnout among pharmacy team members can be minimized through workflow adjustment strategies and cultivating a positive workplace culture.

Practicing mindfulness was associated with fewer psychological symptoms, such as posttraumatic stress, depression, and anxiety.

Ten quiz questions to assess your knowledge on common symptoms and treatments for bipolar disorders.

The trial randomized patients to receive TV-46000 once monthly, TV-46000 once every 2 months, or placebo, and found that patients had improved outcomes on TV-46000 regardless of dosing schedule.

The phase 3 clinical trials evaluated the efficacy and safety of cariprazine as an adjunctive treatment for these patients.

Study addresses the impact of COVID-19 on the mental health of older people.

Kyle Detwiler, CEO of Clever Leaves, discusses his company’s donation of $1 million in medical-grade cannabis to research organizations for the purposes of advancing medical research.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses common themes or key points being raised in the field of psychedelic medicine at recent conferences.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses some best clinical practices for psychedelic-assisted therapy in terms of assessing pharmacological profile.

This is the first large-scale transdiagnostic study of objectively measured sleep and mental health.

Study indicates that women with trauma had greater white matter hyperintensities (WMH) than women without trauma, and the most common trauma associated with WMH was sexual violence.

Investigators reviewed 65 analyses published in the Journal of Affective Disorders showing that by mid-2020 signs were comparable to pre-COVID-19 levels.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, on his recent presentations at Insight 2021 and the virtual Sana Symposium on psychedelic adverse effects and drug-drug interactions.

Evidence of a causal relationship between the onset of allergic disease and mental health was limited, suggesting that the observational associations found were due to confounding or other forms of bias.

Individuals who are insulin-resistant are 2.66 times more likely to suffer from major depression than those who are not insulin-resistant.

Nathan Bryson, PhD, chief scientific officer of Field Trip Health, said the company's new psychedelic compound, FT-104, could have potential uses in the treatment of postpartum depression.

Common and debilitating, the mental health condition is often underdiagnosed and undertreated.

Paula Durlofsky, PhD, a writer for the American Psychological Association's Device Management and Digital Intelligence committee discusses how social media has impacted the mental health of health care professionals in recent years, including the COVID-19 Pandemic.

Walgreens Boots Alliance announces new mental health services including mental health first aid training, Walgreens Find Care, and more partnerships for other mental health resources.

Patients with bulimia may use different methods to get rid of calories and prevent weight gain, such as self-inducing vomiting on a regular basis.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses potential drug-drug interactions with psilocybin, MDMA, and ketamine to consider outside of interactions with psychiatric medications.

Payton Nyquvest, CEO and founder of Numinus, said he believes psychedelic medicines will lead to a significant shift in the mental health treatment landscape in the next 3 to 5 years.

Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses the situations in which serotonin syndrome may be an area of concern when treating patients on psychiatric medication with psychedelic medicine.

Study results shows that patients who have been diagnosed with the disease may face many challenges, which can increase anxiety or depression.